Correvio Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall St slides as hot CPI data fuels rate-hike bets; chips, banks weigh
- Oil prices steady after gains on Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Correvio Pharma (CORV) Tops Q1 EPS by 31c, Revenues Miss
August 14, 2018 4:01 PM EDTCorrevio Pharma (NASDAQ: CORV) reported Q1 EPS of $0.16, $0.31 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $7.07 million.
"The first half of 2018 was marked by several important achievements, including the confirmed ability to resubmit the... More



